The FDA approved Bkemv (eculizumab-aeeb) as the first biosimilar to Soliris (eculizumab) for 2 rare diseases. It was also ...

A literature review revealed new data demonstrating that biosimilar-to-biosimilar switching is safe and effective.

Number 3: The FDA approved the first 2 biosimilars referencing Eylea (aflibercept)—Yesafili (aflibercept-jbvf) and Opuviz ...

The FDA announced that it approved the first 2 biosimilars referencing Eylea (aflibercept) for the treatment of ophthalmic ...

In the IQVIA Use of Medicines in the US 2024 report, biosimilar were found to be large contributors to lower drug costs and ...

The discussion highlighted key emerging trends from the Festival of Biologics conference and the annual Cardinal Health ...

Posters from Digestive Disease Week (DDW) looking at the ongoing LIBERTY-CD trial looking Zymfentra, a subcutaneous ...

Sarfaraz K. Niazi, PhD, congratulates the FDA on approving the fiftieth biosimilar, noting that there's more work to be done ...

Alvotech and Teva have launched Simlandi in the US; Xbrane Biopharma and STADA Arzneimitel partner with Valorum Biologics to ...

Lakesha Farmer from Cencora discusses innovative pricing and reimbursement models incentivizing biosimilar adoption and ...